FerroKin BioSciences, Inc.
http://www.ferrokin.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From FerroKin BioSciences, Inc.
Imago Raises $80m Series C To Take Bomedemstat Into Phase III
The $80m financing will support a Phase III myelofibrosis study for the LSD1 inhibitor and earlier-stage programs, but additional late-stage studies will require an initial public offering, likely next year.
Postmarket Surveillance Reform Board Gets Injection Of Device Industry Experience
The appointments of three device industry veterans to the Brookings-administered, and partially FDA-funded, Planning Board is intended to expand the range of input in the next phase of development of a new National Medical Device Surveillance System.
Medtech Execs On The Move, August 2015
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
InPress Technologies Inc.
There are approximately 140,000 fatalities a year from postpartum hemorrhage, mostly in low- to middle-income countries, and thus a pressing need to reduce mortality. A new low-pressure suction device from InPress Technologies Inc. that is inserted into the uterus following childbirth has the potential to initiate blood control within two minutes and reach full restoration of uterine tone in just over two hours.
Company Information
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice